Design Therapeutics Inc. has described transcription modulators reported to be useful for the treatment of myotonic dystrophy type 1 (DM1) and Fuchs’ dystrophy.
A retired lecturer from Edinburgh will be able to see Christmas properly for the first time in years after receiving a ...
David Watkins, 72, from Edinburgh had to sit in the dark and wear sunglasses all the time before he underwent surgery which ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback